Currently, commonly used urinary biomarkers for LN include urinary alpha 1-microglobulin (u-α1MG), urinary-beta2-microglobulin (u-β2MG), urinary immunoglobulin G (u-IgG), and urinary microalbumin (u-ALB) [16–19]. Here, ALB is linked to lobular neoplasia.